Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros

Bases de datos
Tipo de estudio
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
J Neurosci ; 32(19): 6732-42, 2012 May 09.
Artículo en Inglés | MEDLINE | ID: mdl-22573696

RESUMEN

Excessive NMDA receptor activation and excitotoxicity underlies pathology in many neuropsychiatric and neurological disorders, including hypoxia/ischemia. Thus, the development of effective therapeutics for these disorders demands a complete understanding of NMDA receptor (NMDAR) activation during excitotoxic insults. The extrasynaptic NMDAR hypothesis posits that synaptic NMDARs are neurotrophic/neuroprotective and extrasynaptic NMDARs are neurotoxic. The extrasynaptic hypothesis is built in part on observed selectivity for extrasynaptic receptors of a neuroprotective use-dependent NMDAR channel blocker, memantine. In rat hippocampal neurons, we found that a neuroprotective concentration of memantine shows little selectivity for extrasynaptic NMDARs when all receptors are tonically activated by exogenous glutamate. This led us to test the extrasynaptic NMDAR hypothesis using metabolic challenge, where the source of excitotoxic glutamate buildup may be largely synaptic. Three independent approaches suggest strongly that synaptic receptors participate prominently in hypoxic excitotoxicity. First, block of glutamate transporters with a nonsubstrate antagonist exacerbated rather than prevented damage, consistent with a primarily synaptic source of glutamate. Second, selective, preblock of synaptic NMDARs with a slowly reversible, use-dependent antagonist protected nearly fully against prolonged hypoxic insult. Third, glutamate pyruvate transaminase, which degrades ambient but not synaptic glutamate, did not protect against hypoxia but protected against exogenous glutamate damage. Together, these results suggest that synaptic NMDARs can mediate excitotoxicity, particularly when the glutamate source is synaptic and when synaptic receptor contributions are rigorously defined. Moreover, the results suggest that in some situations therapeutically targeting extrasynaptic receptors may be inappropriate.


Asunto(s)
Hipoxia de la Célula/fisiología , Potenciales Postsinápticos Excitadores/fisiología , Receptores de N-Metil-D-Aspartato/fisiología , Receptores de Neurotransmisores/fisiología , Animales , Animales Recién Nacidos , Muerte Celular/fisiología , Células Cultivadas , Masculino , Ratas , Ratas Sprague-Dawley
2.
Neurobiol Dis ; 43(2): 516-25, 2011 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-21605675

RESUMEN

Glutamate release is a root cause of acute and delayed neuronal damage in response to hypoxic/ischemic insults. Nevertheless, therapeutics that target the postsynaptic compartment have been disappointing clinically. Here we explored whether presynaptic silencing (muting) of glutamatergic terminals is sufficient to reduce excitotoxic damage resulting from hypoxia and oxygen/glucose deprivation. Our evidence suggests that strong depolarization, previously shown to mute glutamate synapses, protects neurons by a presynaptic mechanism that is sensitive to inhibition of the proteasome. Postsynaptic Ca2+ rises in response to glutamate application and toxicity in response to exogenous glutamate treatment were unaffected by depolarization preconditioning. These features strongly suggest that reduced glutamate release explains preconditioning protection. We addressed whether hypoxic depolarization itself induces presynaptic silencing, thereby participating in the damage threshold for hypoxic insult. Indeed, we found that the hypoxic insult increased the percentage of mute glutamate synapses in a proteasome-dependent manner. Furthermore, proteasome inhibition exacerbated neuronal loss to mild hypoxia and prevented hypoxia-induced muting. In total our results suggest that presynaptic silencing is an endogenous neuroprotective mechanism that could be exploited to reduce damage from insults involving excess synaptic glutamate release.


Asunto(s)
Ácido Glutámico/metabolismo , Hipoxia-Isquemia Encefálica/metabolismo , Inhibición Neural/fisiología , Neurotoxinas/metabolismo , Terminales Presinápticos/metabolismo , Transmisión Sináptica/fisiología , Animales , Animales Recién Nacidos , Señalización del Calcio/fisiología , Células Cultivadas , Modelos Animales de Enfermedad , Potenciales Postsinápticos Excitadores/fisiología , Femenino , Ácido Glutámico/toxicidad , Hipocampo/citología , Hipoxia-Isquemia Encefálica/fisiopatología , Precondicionamiento Isquémico/métodos , Masculino , Complejo de la Endopetidasa Proteasomal/metabolismo , Inhibidores de Proteasoma , Ratas , Transmisión Sináptica/efectos de los fármacos
3.
Biophys J ; 95(1): 176-85, 2008 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-18339741

RESUMEN

We investigated the electrophysiological signature of neuroactive steroid interactions with the plasma membrane. We found that charged, sulfated neuroactive steroids, those that exhibit noncompetitive antagonism of GABA(A) receptors, altered capacitive charge movement in response to voltage pulses in cells lacking GABA receptors. Uncharged steroids, some of which are potent enhancers of GABA(A) receptor activity, produced no alteration in membrane capacitance. We hypothesized that the charge movements might result from physical translocation of the charged steroid through the transmembrane voltage, as has been observed previously with several hydrophobic anions. However, the charge movements and relaxation time constants of capacitive currents did not exhibit the Boltzmann-type voltage dependence predicted by a single barrier model. Further, a fluorescently tagged analog of a sulfated neurosteroid altered membrane capacitance similar to the parent compound but produced no voltage-dependent fluorescence change, a result inconsistent with a strong change in the polar environment of the fluorophore during depolarization. These findings suggest that negatively charged sulfated steroids alter the plasma membrane capacitance without physical movement of the molecule through the electric field.


Asunto(s)
Membrana Celular/fisiología , Antagonistas de Receptores de GABA-A , Potenciales de la Membrana/fisiología , Oocitos/fisiología , Receptores de GABA-A/metabolismo , Esteroides/administración & dosificación , Esteroides/metabolismo , Animales , Células Cultivadas , Capacidad Eléctrica , Xenopus laevis
4.
PLoS One ; 6(9): e25633, 2011.
Artículo en Inglés | MEDLINE | ID: mdl-21980512

RESUMEN

Neurobasal defined culture medium has been optimized for survival of rat embryonic hippocampal neurons and is now widely used for many types of primary neuronal cell culture. Therefore, we were surprised that routine medium exchange with serum- and supplement-free Neurobasal killed as many as 50% of postnatal hippocampal neurons after a 4 h exposure at day in vitro 12-15. Minimal Essential Medium (MEM), in contrast, produced no significant toxicity. Detectable Neurobasal-induced neuronal death occurred with as little as 5 min exposure, measured 24 h later. D-2-Amino-5-phosphonovalerate (D-APV) completely prevented Neurobasal toxicity, implicating direct or indirect N-methyl-D-aspartate (NMDA) receptor-mediated neuronal excitotoxicity. Whole-cell recordings revealed that Neurobasal but not MEM directly activated D-APV-sensitive currents similar in amplitude to those gated by 1 µM glutamate. We hypothesized that L-cysteine likely mediates the excitotoxic effects of Neurobasal incubation. Although the original published formulation of Neurobasal contained only 10 µM L-cysteine, commercial recipes contain 260 µM, a concentration in the range reported to activate NMDA receptors. Consistent with our hypothesis, 260 µM L-cysteine in bicarbonate-buffered saline gated NMDA receptor currents and produced toxicity equivalent to Neurobasal. Although NMDA receptor-mediated depolarization and Ca²âº influx may support survival of young neurons, NMDA receptor agonist effects on development and survival should be considered when employing Neurobasal culture medium.


Asunto(s)
Medios de Cultivo/toxicidad , Neuronas/citología , Neuronas/efectos de los fármacos , Neurotoxinas/toxicidad , Animales , Técnicas de Cultivo de Célula , Muerte Celular/efectos de los fármacos , Medios de Cultivo/química , Cisteína/toxicidad , Conductividad Eléctrica , Femenino , Hipocampo/citología , Masculino , N-Metilaspartato/agonistas , Neuronas/metabolismo , Ratas , Receptores de N-Metil-D-Aspartato/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA